News

  • ALL WOMEN study enrollment completed

    ALL WOMEN Study – Enrollment Completed

    -

    We are proud to share that the ALL WOMEN study has successfully reached its enrollment goal, and patient inclusion is now completed. Thank you to everyone involved for your strong commitment and teamwork. The next focus is data completion for primary endpoint communications. Learn more about the ALL...

  • CERC members at HighTech Cardio Congress

    Great moments at the HIGH TECH Cardio Congress in Marseille

    -

    Several CERC members attended the High Tech Cardio Congress in Marseille, a leading international event dedicated to innovation in cardiovascular medicine. CERC members Antoinette Neylon, Thomas Cuisset, Philippe Garot, and Didier Tchétché were present at the congress and actively participated in...

  • High-Impact Publications Across the Years CERC

    High-Impact Publications Across the Years

    -

    CERC is proud to support the publication of clinical trial results, working closely with investigators and sponsors to ensure high-quality scientific output and visibility in leading peer-reviewed journals. In 2025, CERC-supported studies resulted in 15 publications in major international journals...

  • ABILITY Diabetes Global Study Published in The Lancet

    ABILITY Diabetes Global Study Published in The Lancet

    -

    The ABILITY Diabetes Global study has now been officially published in The Lancet, marking an important milestone for this large international clinical trial. The study was conducted under the scientific leadership of Mount Sinai and sponsored by Concept Medical, with the active involvement of a...

  • CERC PCR London Valves 2025 booth A27

    CERC at PCR London Valves 2025

    -

    CERC will be present at PCR London Valves 2025, from 16 to 18 November in London. As a specialized cardiovascular CRO, CERC partners with leading innovators to transform ideas into successful clinical outcomes, from concept to completion, worldwide. Our team will be on site to share CERC’s expertise...

  • 12-month results of the landmark SELUTION DeNovo trial

    12-month results of the landmark SELUTION DeNovo trial

    -

    Major milestone in interventional cardiology! At TCT2025, Prof. Christian Spaulding presented the 12-month results of the landmark SELUTION DeNovo trial. The study demonstrated that a treatment strategy using SELUTION SLR™ Drug-Eluting Balloon with provisional stenting when needed, was non-inferior...

  • ABILITY DIABETES GLOBAL Trial accepted in The Lancet

    ABILITY DIABETES GLOBAL Trial accepted in The Lancet

    -

    CERC is proud to share that the ABILITY DIABETES GLOBAL Trial has been accepted for publication in The Lancet. Conducted under the leadership of Dr. Roxana Mehran, this study reflects a successful collaboration between Mount Sinai and CERC as CRO.

  • CERC Asia at AICT asia PCR 2025

    Wrapping up AICT AsiaPCR 2025

    -

    CERC (Cardiovascular European Research Center) was proud to take part in AICT AsiaPCR 2025 in Singapore this weekend. The congress opened with an impressive live educational case on left main PCI, featuring several members of the CERC Asia (Cardiovascular European Research Center Asia) Board...

  • CERC News

    CERC at EuroPCR 2025

    -

    During this EuroPCR week, the CERC team was proud to see numerous clinical studies featured in key sessions across the EuroPCR 2025 programme.

  • CERC News

    LAARC Initiative: Towards a Unified Approach in Stroke Prevention Trials

    -

    On March 17th, 2025, the second meeting of the LAARC initiative took place. Led by CERC within the framework of the Academic Research Consortium, this initiative aims to standardize definitions and clinical trial endpoints used in studies evaluating stroke prevention through left atrial appendage...